(1 - 13 from 15
)
StemCells Names Stephen Huhn as Chief Medical Officer - Benzinga
www.benzinga.com
Get News First. Profit Faster With Benzinga Professional get unlimited access to ALL content! PLUS: REALTIME NEWSFEED REALTIME AUDIO NEWS FULL CALENDAR ...
FDA approves stem cell trial for dry AMD - Optician
www.opticianonline.net
The US Food and Drug Administration has authorised the initiation of a Phase I/II clinical trial of US company StemCells' purified human neural stem cells
Macular Degeneration Stem Cell Clinical Trial Results Allow for Phase...
retinafoundation.org
Dr. Stephen Huhn, Vice President of Clinical Research and Chief Medical Officer of StemCells, Inc. states, “the first active site is enrolling and we plan to have ...
StemCells, Inc. Completes Enrollment of First Cohort in Phase II...
orthospinenews.com
“We are breaking new ground with this study,” said Stephen Huhn, M.D., FACS, FAAP, vice president, CNS clinical research and CMO at Jul Jul
AOSSM Annual Meeting Jul - 1 Aug
International Spine Sep - 4 Sep
EuroSpine
sorted by relevance / date